Soleus Private Equity Fund III L.P. 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 4:15 pm Sale | 2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | Soleus Private Equity Fund III L.P. | 1,820,365 9.990% | -47,690 (-2.55%) | Filing |
| 2023-10-26 5:00 pm Purchase | 2023-10-25 | 13G | Harpoon Therapeutics, Inc. HARP | Soleus Private Equity Fund III L.P. | 1,868,055 9.990% | 1,868,055 (New Position) | Filing |